title: Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
authors.forename: A
authors.initials: A
authors.lastname: Foli
authors.forename: R
authors.initials: R
authors.lastname: Maserati
authors.forename: L
authors.initials: L
authors.lastname: Minoli
authors.forename: M A
authors.initials: MA
authors.lastname: Wainberg
authors.forename: R C
authors.initials: RC
authors.lastname: Gallo
authors.forename: J
authors.initials: J
authors.lastname: Lisziewicz
authors.forename: F
authors.initials: F
authors.lastname: Lori
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D016049:Didanosine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D016049:Didanosine; D006918:Hydroxyurea